These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 9166528

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Radiosensitization research in cancer therapy].
    Sugahara T.
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):405-11. PubMed ID: 3890755
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. COX-2 inhibitors as radiosensitizing agents for cancer therapy.
    Davis TW, Hunter N, Trifan OC, Milas L, Masferrer JL.
    Am J Clin Oncol; 2003 Aug; 26(4):S58-61. PubMed ID: 12902857
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Arrhenius relationships from the molecule and cell to the clinic.
    Dewey WC.
    Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695
    [Abstract] [Full Text] [Related]

  • 10. New concepts for phase I trials: evaluating new drugs combined with radiation therapy.
    Deutsch E, Soria JC, Armand JP.
    Nat Clin Pract Oncol; 2005 Sep; 2(9):456-65. PubMed ID: 16264990
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenografts.
    Vink SR, Lagerwerf S, Mesman E, Schellens JH, Begg AC, van Blitterswijk WJ, Verheij M.
    Clin Cancer Res; 2006 Mar 01; 12(5):1615-22. PubMed ID: 16533789
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Radiosensitizers: rationale and potential.
    Brown JM.
    Cancer Treat Rep; 1981 Mar 01; 65 Suppl 2():95-102. PubMed ID: 7346152
    [Abstract] [Full Text] [Related]

  • 16. Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directions.
    Bentzen SM, Harari PM, Bernier J.
    Nat Clin Pract Oncol; 2007 Mar 01; 4(3):172-80. PubMed ID: 17327857
    [Abstract] [Full Text] [Related]

  • 17. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD, Flickinger JC, Larson D.
    Oncologist; 1997 Mar 01; 2(1):59-61. PubMed ID: 10388030
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Photon activation therapy.
    Fairchild RG, Bond VP.
    Strahlentherapie; 1984 Dec 01; 160(12):758-63. PubMed ID: 6515666
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.